PB-718

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePB-718
Drug Alias NamePegylated exenatide/PB 722Pegylated exenatide/PB-722PB-119/PB-722PB-718
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsOverweightObesityCongenital Hyperinsulinism +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPeg Bio Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTasly (Hong Kong) Pharmaceuticals LtdPeg Bio Co LtdTianjin Tasly Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesityCongenital Hyperinsulinism +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A